Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19704057 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown 
Has Results
Study to Investigate the Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut
Condition: Neuroendocrine Tumors
Interventions: Drug: Octreotide LAR (Long-acting release);   Drug: Placebo

Indicates status has not been verified in more than two years